Literature DB >> 7927731

Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification.

J J Weis1, Y Ma, L F Erdile.   

Abstract

Borrelia burgdorferi lipoproteins are 50- to 500-fold more active as cytokine inducers and B-cell mitogens than Escherichia coli lipoproteins and synthetic peptides containing the tripalmitoyl-S-glyceryl-cysteine moiety. To investigate the source of this unique potency, we compared native OspA from B. burgdorferi with recombinant lipidated OspA produced in E. coli. As little as 10 ng of either protein per ml stimulated B-cell proliferation and production of cytokines and nitric oxide by macrophages. The two proteins induced comparable antibody responses in mice. Nonlipidated OspA made in E. coli had no stimulatory activity. Thus, lipid modification is essential both in vivo and in vitro for the immunological properties of OspA. The lipid moiety appears equally active whether produced in B. burgdorferi or in E. coli.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927731      PMCID: PMC303154          DOI: 10.1128/iai.62.10.4632-4636.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides.

Authors:  D C Morrison; D M Jacobs
Journal:  Immunochemistry       Date:  1976-10

2.  Isolation of interleukin 1 from joint fluids of patients with Lyme disease.

Authors:  G Beck; J L Benach; G S Habicht
Journal:  J Rheumatol       Date:  1989-06       Impact factor: 4.666

3.  Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody.

Authors:  A G Barbour; S L Tessier; W J Todd
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

4.  Stimulation of human and murine adherent cells by bacterial lipoprotein and synthetic lipopeptide analogues.

Authors:  P Hoffmann; S Heinle; U F Schade; H Loppnow; A J Ulmer; H D Flad; G Jung; W G Bessler
Journal:  Immunobiology       Date:  1988-05       Impact factor: 3.144

5.  In vivo and in vitro evidence of B cell hyperactivity during Lyme disease.

Authors:  L H Sigal; A C Steere; J M Dwyer
Journal:  J Rheumatol       Date:  1988-04       Impact factor: 4.666

6.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

7.  Specific and nonspecific responses of murine B cells to membrane blebs of Borrelia burgdorferi.

Authors:  W M Whitmire; C F Garon
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.

Authors:  W G Bessler; M Cox; A Lex; B Suhr; K H Wiesmüller; G Jung
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

9.  Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.

Authors:  J C Drapier; J Wietzerbin; J B Hibbs
Journal:  Eur J Immunol       Date:  1988-10       Impact factor: 5.532

10.  The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen.

Authors:  F Melchers; V Braun; C Galanos
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

View more
  43 in total

1.  Expression and secretion of recombinant outer-surface protein A from the Lyme disease agent, Borrelia burgdorferi, in Nicotiana tabacum suspension cells.

Authors:  Catherine Navarre; Mélanie Delannoy; Benoit Lefebvre; Joseph Nader; Delphine Vanham; Marc Boutry
Journal:  Transgenic Res       Date:  2006-06       Impact factor: 2.788

2.  Lipopeptides of Borrelia burgdorferi outer surface proteins induce Th1 phenotype development in alphabeta T-cell receptor transgenic mice.

Authors:  C Infante-Duarte; T Kamradt
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae.

Authors:  Harald Gelderblom; Jens Schmidt; Diana Londoño; Yunhong Bai; Jacqueline Quandt; Ron Hornung; Adriana Marques; Roland Martin; Diego Cadavid
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 4.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

5.  Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex.

Authors:  Diana Rose E Ranoa; Stacy L Kelley; Richard I Tapping
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

6.  Bacterial lipoproteins can disseminate from the periphery to inflame the brain.

Authors:  Diana Londoño; Diego Cadavid
Journal:  Am J Pathol       Date:  2010-04-29       Impact factor: 4.307

7.  Evaluation of the Borrelia burgdorferi BBA64 protein as a protective immunogen in mice.

Authors:  Kevin S Brandt; Toni G Patton; Anna S Allard; Melissa J Caimano; Justin D Radolf; Robert D Gilmore
Journal:  Clin Vaccine Immunol       Date:  2014-02-05

8.  Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.

Authors:  Rhonda L LaFleur; Jennifer C Dant; Terri L Wasmoen; Steven M Callister; Dean A Jobe; Steven D Lovrich; Thomas F Warner; O Abdelmagid; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2008-12-03

9.  Immune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigen.

Authors:  Beatriz del Rio; Jos F M L Seegers; Maria Gomes-Solecki
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

10.  Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.

Authors:  K P Seiler; Z Vavrin; E Eichwald; J B Hibbs; J J Weis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.